| |
|
|
|
Xtalks, Online
2024-04-22
In the webinar “Countdown to Crunch Time: How Early and Continual Regulatory Engagement Leads to Regulatory and Commercial Success,” industry-leading regulators with extensive experience in both the biopharma and the CRO space engage in a not-to-be-missed, dynamic conversation. Participants will uncover vital strategies for navigating regulatory pathways seamlessly. By avoiding common pitfalls that could jeopardize submission deadlines, attendees will gain invaluable insights into safeguarding project timelines.
Additionally, this webinar will shed light on the often-overlooked advantages of early and continual engagement with regulatory agencies and how proactive collaborative efforts in the early stages can significantly enhance efficiency and mitigate risks. By sharing lessons learned and expert strategies, participants will be well-equipped to streamline their regulatory journey, ensuring overall success.
Register for this webinar today to gain insights into the advantages of early and continual regulatory engagement.
Keywords: Clinical Trials, Drug Development, CRO, Regulatory, Regulatory Approval, Regulatory Affairs, Regulatory Compliance
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Linda Bowen, MS, RAC (US, EU, CAN), FRAPS, Business Operations and Integration Lead, Oncology Global Regulatory Strategy, Pfizer
Aman Khera, MBA, FRAPS, FTOPRA, Vice President, Regulatory Science, Strategy and Innovation, Worldwide Clinical Trials
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2024-04-22
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|